BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38643693)

  • 41. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.
    Shen Y; Li W
    Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer.
    Zhao X; Shen R; Bao L; Wang C; Yuan H
    Carbohydr Polym; 2020 Oct; 245():116509. PubMed ID: 32718620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
    S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.
    Zhao Y; Zhang T; Duan S; Davies NM; Forrest ML
    Nanomedicine; 2014 Aug; 10(6):1221-30. PubMed ID: 24637218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan.
    Chatterjee S; Hui PC; Siu WS; Kan CW; Leung PC; Wanxue C; Chiou JC
    Int J Biol Macromol; 2021 Jan; 168():163-174. PubMed ID: 33309656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissolving Hyaluronic Acid-Based Microneedles to Transdermally Deliver Eugenol Combined with Photothermal Therapy for Acne Vulgaris Treatment.
    Wang Q; Gan Z; Wang X; Li X; Zhao L; Li D; Xu Z; Mu C; Ge L; Li D
    ACS Appl Mater Interfaces; 2024 May; 16(17):21595-21609. PubMed ID: 38635857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
    Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
    Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
    Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
    Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
    Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chitosan-coated hydroxyapatite and drug-loaded polytrimethylene carbonate/polylactic acid scaffold for enhancing bone regeneration.
    He J; Hu X; Cao J; Zhang Y; Xiao J; Peng L; Chen D; Xiong C; Zhang L
    Carbohydr Polym; 2021 Feb; 253():117198. PubMed ID: 33278972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.
    Pramanik A; Xu Z; Ingram N; Coletta PL; Millner PA; Tyler AII; Hughes TA
    Mol Pharm; 2022 Dec; 19(12):4601-4611. PubMed ID: 35938983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wound healing potential of antibacterial microneedles loaded with green tea extracts.
    Park SY; Lee HU; Lee YC; Kim GH; Park EC; Han SH; Lee JG; Choi S; Heo NS; Kim DL; Huh YS; Lee J
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():757-62. PubMed ID: 25063177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.